Updated:
BayMed Venture Partners
BayMed Venture Partners identifies and mentors innovative maturing early-stage medical device and digital health companies in North America and Israel.
Overview
BayMed Venture Partners identifies and mentors innovative maturing early-stage medical device and digital health companies in North America and Israel. The firm focuses on unmet clinical needs and disruptive innovation, applying deep clinical and operational expertise. It aims to advance breakthrough solutions that deliver value for portfolio companies, investment partners, and the global healthcare system.
General information
Firm type
Venture Capital
Year founded
2020
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Gary Gershony
MD — Founding General Partner
Neil Meyer — Founding General Partner
Gregg W. Stone
MD — Advisor and clinical key opinion leader
Leslie Saxon
MD — Advisor and digital health key opinion leader
Martin T. Rothman
MD — Advisor and industry key opinion leader
Amanda White — Senior Associate
Sector focus
Frequently asked questions
What investment stages does BayMed Venture Partners target?
BayMed invests across early-stage, expansion, and growth-stage companies. The firm's stage flexibility reflects the capital-intensive nature of life sciences, where companies often need funding through clinical trials, regulatory approvals, and early commercialization before reaching revenue scale. This multi-stage approach allows BayMed to support portfolio companies from pre-revenue R&D through market expansion.
Which healthcare subsectors does BayMed focus on?
The firm targets the convergence of technology and life sciences, with a mandate spanning medical devices, digital health, and healthcare services. BayMed's thesis centers on innovations that navigate the intersection of clinical science and commercial scalability — companies that require both technical validation and regulatory clearance to reach the market.
Does BayMed Venture Partners manage a single fund or multiple vehicles?
Public records do not confirm the firm's specific fund structure, total assets under management, or number of vehicles. BayMed's website provides limited disclosure on fundraising history. Institutional allocators should request fund-level track records and vehicle documentation directly from the firm.
Is BayMed Venture Partners registered with the SEC as an investment adviser?
Registration status is not confirmed through the firm's limited public disclosures. Institutional counterparties conducting due diligence should verify BayMed's regulatory filings and Form ADV through the SEC's Investment Adviser Public Disclosure database to determine registration status, disciplinary history, and reported assets.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: